PLUS Stock Analysis: ePlus | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 2.382m USD | 12M Return: 29.4% | US2942681071 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 18.7M
EPS Trend: -36.7%
Qual. Beats: 0
Rev. Trend: 52.5%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
ePlus inc. (NASDAQ: PLUS) is a Herndon, Virginia-based provider of IT solutions, founded in 1990 and renamed from MLC Holdings in 1999. The company operates through three segments - Product Services, Professional Services, and Managed Services - selling third-party hardware, perpetual and subscription software, and maintenance, and offering internet-based B2B supply chain management for IT products.
Its Professional Services include staff augmentation, project management, cloud consulting, AI advisory, security, and logistics, while Managed Services cover service desk, storage-as-a-service, cloud management, and managed security. ePlus serves customers in telecommunications, media, technology, state and local government, education, healthcare, and financial services across the U.S. and internationally.
Classified under GICS as a Technology Distributor, ePlus follows a hybrid value-added reseller model, pairing third-party product resale with higher-margin advisory and recurring managed services - a structure common among mid-cap IT resellers seeking to extend customer relationships beyond hardware and software transactions.
- Product segment revenue pressured by soft enterprise hardware spending
- Managed services growth lifts mix toward higher margin recurring revenue
- AI advisory and cloud consulting drive professional services demand
| Net Income: 125.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -2.66 > 1.0 |
| NWC/Revenue: 32.45% < 20% (prev 33.39%; Δ -0.94% < -1%) |
| CFO/TA 0.03 > 3% & CFO 59.2m > Net Income 125.8m |
| Net Debt (-424.7m) to EBITDA (198.7m): -2.14 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.1m) vs 12m ago -1.21% < -2% |
| Gross Margin: 24.71% > 18% (prev 25.85%; Δ -1.14% > 0.5%) |
| Asset Turnover: 133.9% > 50% (prev 118.9%; Δ 14.96% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.43 (Total Current Assets 1.50b - Total Current Liabilities 704.3m) / Total Assets 1.87b |
| B: 0.52 (Retained Earnings 979.2m / Total Assets 1.87b) |
| C: 0.09 (EBIT TTM 172.3m / Avg Total Assets 1.83b) |
| D: 1.35 (Book Value of Equity 1.07b / Total Liabilities 795.0m) |
| Altman-Z'' = 6.56 = AAA |
| DSRI: 0.92 (Receivables 783.3m/739.5m, Revenue 2.45b/2.14b) |
| GMI: 1.05 (GM 25.85% / 24.71%) |
| AQI: 0.89 (AQ_t 0.14 / AQ_t-1 0.16) |
| SGI: 1.15 (Revenue 2.45b / 2.14b) |
| TATA: 0.04 (NI 125.8m - CFO 59.2m) / TA 1.87b) |
| Beneish M = -3.00 (Cap -4..+1) = AA |
As of September 27, 2026, the stock is trading at USD 90.51 with a total of 137,306 shares traded. Over the past week, the price has changed by -0.65%, over one month by +4.81%, over three months by +12.01% and over the past year by +29.37%.
Current recommended Stop Loss: 85.90 (which is 5.1% or 1.8 ATR below the current price).
ePlus has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy PLUS.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 111 | 22.6% |
P/E Trailing = 19.7614
P/E Forward = 17.1821
P/S = 0.9706
P/B = 2.239
P/EG = 1.0748
Revenue TTM = 2.45b USD
EBIT TTM = 172.3m USD
EBITDA TTM = 198.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 112.5m USD (from shortLongTermDebt, last quarter)
Debt = 24.1m USD (from shortLongTermDebtTotal, last fiscal year) + Leases 7.95m
Net Debt = -424.7m USD (calculated: Debt 24.1m - CCE 448.9m)
Enterprise Value = 1.96b USD (2.38b + Debt 24.1m - CCE 448.9m)
Interest Coverage Ratio = unknown (Ebit TTM 172.3m / Interest Expense TTM 0.0)
EV/FCF = 35.75x (Enterprise Value 1.96b / FCF TTM 54.8m)
FCF Yield = 2.80% (FCF TTM 54.8m / Enterprise Value 1.96b)
FCF Margin = 2.23% (FCF TTM 54.8m / Revenue TTM 2.45b)
Net Margin = 5.12% (Net Income TTM 125.8m / Revenue TTM 2.45b)
Gross Margin = 24.71% ((Revenue TTM 2.45b - Cost of Revenue TTM 1.85b) / Revenue TTM)
Gross Margin QoQ = 23.31% (prev 24.23%)
Tobins Q-Ratio = 1.05 (Enterprise Value 1.96b / Total Assets 1.87b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 24.1m)
Taxrate = 28.73% (51.3m / 178.6m)
NOPAT = 122.8m (EBIT 172.3m * (1 - 28.73%))
Current Ratio = 2.13 (Total Current Assets 1.50b / Total Current Liabilities 704.3m)
Debt / Equity = 0.02 (Debt 24.1m / totalStockholderEquity, last quarter 1.07b)
Debt / EBITDA = -2.14 (Net Debt -424.7m / EBITDA 198.7m)
Debt / FCF = -7.75 (Net Debt -424.7m / FCF TTM 54.8m)
Total Stockholder Equity = 1.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.86% (Net Income 125.8m / Total Assets 1.87b)
RoE = 11.84% (Net Income TTM 125.8m / Total Stockholder Equity 1.06b)
RoCE = 14.82% (EBIT 172.3m / Capital Employed (Total Assets 1.87b - Current Liab 704.3m))
RoIC = 11.75% (NOPAT 122.8m / Invested Capital 1.05b)
WACC = 7.99% (E(2.38b)/V(2.41b) * Re(8.07%) + D(24.1m)/V(2.41b) * Rd(0.0%) * (1-Tc(0.29)))
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.78 | Cagr: -1.24%
[DCF] Terminal Value 73.10% ; FCFF base≈73.1m ; Y1≈64.1m ; Y5≈51.8m
[DCF] Fair Price = 48.03 (EV 831.3m - Net Debt -424.7m = Equity 1.26b / Shares 26.2m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -36.73 | EPS CAGR: -2.67% | SUE: 0.71 | # QB: 0
Revenue Correlation: 52.52 | Revenue CAGR: 3.59% | SUE: 0.13 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.47 | Chg30d=-4.23% | Revisions=-40% | Analysts=2
EPS next Quarter (2026-12-31): EPS=1.53 | Chg30d=+1.32% | Revisions=+0% | Analysts=2
EPS current Year (2027-03-31): EPS=5.47 | Chg30d=+2.72% | Revisions=+40% | GrowthEPS=+1.6% | GrowthRev=+4.7%
EPS next Year (2028-03-31): EPS=5.96 | Chg30d=+2.58% | Revisions=+40% | GrowthEPS=+8.8% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +18% (up=5, down=3)